First Week of March 20th Options Trading For Mobileye Global (MBLY)

Mobileye (MBLY) is trading at $10.85 and the article outlines two option strategies: a sell-to-open $9.00 put (bid $0.20) which would set an effective cost basis of $8.80 and is ~17% out-of-the-money with a 75% analytic probability of expiring worthless, producing a 2.22% return (12.88% annualized) if so. The covered-call example sells the $12.00 call (bid $0.71) against shares bought at $10.85, representing an ~11% upside to strike and a 47% chance of expiring worthless; if called at the March 20 expiration the total return would be ~17.14% (the premium alone equals a 6.54% boost or 37.94% annualized). Implied volatilities are elevated (put 135%, call 115%) versus trailing 12-month realized vol of 56%, and Stock Options Channel will track odds and contract histories on its site.

Analysis

Market structure: The option chain shows sellers of downside protection (cash-secured put at $9) and covered-call writers (buy-write into $12) stand to benefit from richly-priced implied vol (puts IV 135%, calls 115%) versus realized vol ~56%. The $9 put sits ~17% below spot and the $12 call ~11% above; those strikes quantify market willingness to sell downside insurance vs cap upside over the March 20 expiry. Elevated put skew implies investor demand for downside hedges in MBLY specifically, not broad market stress, signaling stock-specific sentiment imbalance.

Risk assessment: Tail risks include an OEM contract loss, adverse regulatory ruling on AV tech, or a sharp macro selloff that compresses liquidity — any could compress realized recovery and push MBLY < $7.50 (a practical pain threshold). Immediate horizon (next 30 days) is dominated by option expiry and IV mean-reversion; 3–6 months cover OEM disclosures and quarterlies; 12–36 months cover commercialization/adoption of ADAS and revenue cadence. Hidden dependency: valuation and volatility pricing reflect both Mobileye-specific execution and broader auto-semiconductor cyclicality (supply chain and chip demand).

Trade implications: Direct actionable plays are asymmetric option sells because IV >> realized: (A) cash‑secured $9 put for ~ $0.20 (2.2% cash yield, 12.9% annualized) sized small (0.5–1% portfolio), with a protective buy at $7.50 or defined put‑spread ($9/$7.50) to cap downside; (B) buy-write at $10.85 sell $12 call to harvest ~17% to cap by Mar 20. If you prefer delta‑neutral, implement put spreads or short strangles sized to IV and avoid naked short vol >1% portfolio. Consider a relative trade: long MBLY vs short Aptiv (APTV) to isolate software/ADAS upside.

Contrarian angles: Consensus underweights that IV >> realized — a disciplined premium-selling program can earn carry if no fundamental shock occurs, but assignment risk and concentrated equity exposure are underappreciated. The market may be under-pricing the probability of a binary OEM contract or regulatory shock; past episodes (2020 volatile names) show sellers of cheap premium can be crushed by assignment during regime shifts. Manage size, use protection (buy lower strikes) and treat these as yield-enhancement, not directional core positions.

Key Decisions for Investors

• Sell 1x cash‑secured MBLY Mar 20 $9 put (collect ~ $0.20) per 100 shares exposure — size to 0.5–1.0% of portfolio; set hard exit if MBLY < $7.50 or if assigned, buy $7.50 put to cap further downside.
• Establish a buy‑write: purchase MBLY up to $10.85 and sell Mar 20 $12 call (net upside ~17% if called); position size 1–2% portfolio, close position early if MBLY > $12 or if IV collapses >30 implied vol points.
• If unwilling to take assignment, sell a defined-risk put spread MBLY Mar 20 $9/$7.50 (caps max loss at $1.50 width less premium) instead of naked put — target net credit ≈ $0.15–$0.25; enter within next 2 weeks to capture current IV.
• Implement a small pair trade to express ADAS idiosyncratic upside: go long MBLY (or buy‑write) and short Aptiv (APTV) sized 1:0.4 to reduce macro/auto-cycle risk; allocate 0.5–1% net and re‑balance after the next quarterly report.